1. Home
  2. IVA vs CZNC Comparison

IVA vs CZNC Comparison

Compare IVA & CZNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • CZNC
  • Stock Information
  • Founded
  • IVA 2011
  • CZNC 1864
  • Country
  • IVA France
  • CZNC United States
  • Employees
  • IVA N/A
  • CZNC N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • CZNC Major Banks
  • Sector
  • IVA Health Care
  • CZNC Finance
  • Exchange
  • IVA Nasdaq
  • CZNC Nasdaq
  • Market Cap
  • IVA 359.6M
  • CZNC 297.0M
  • IPO Year
  • IVA 2020
  • CZNC N/A
  • Fundamental
  • Price
  • IVA $2.97
  • CZNC $19.22
  • Analyst Decision
  • IVA Strong Buy
  • CZNC
  • Analyst Count
  • IVA 4
  • CZNC 0
  • Target Price
  • IVA $10.50
  • CZNC N/A
  • AVG Volume (30 Days)
  • IVA 15.3K
  • CZNC 30.1K
  • Earning Date
  • IVA 09-24-2025
  • CZNC 08-06-2025
  • Dividend Yield
  • IVA N/A
  • CZNC 5.83%
  • EPS Growth
  • IVA N/A
  • CZNC 15.59
  • EPS
  • IVA N/A
  • CZNC 1.75
  • Revenue
  • IVA $14,591,573.00
  • CZNC $108,310,000.00
  • Revenue This Year
  • IVA $15.38
  • CZNC $6.78
  • Revenue Next Year
  • IVA $24.22
  • CZNC $4.59
  • P/E Ratio
  • IVA N/A
  • CZNC $11.01
  • Revenue Growth
  • IVA N/A
  • CZNC 4.96
  • 52 Week Low
  • IVA $1.53
  • CZNC $17.25
  • 52 Week High
  • IVA $4.05
  • CZNC $22.68
  • Technical
  • Relative Strength Index (RSI)
  • IVA 38.99
  • CZNC 46.38
  • Support Level
  • IVA $3.12
  • CZNC $19.33
  • Resistance Level
  • IVA $3.61
  • CZNC $19.99
  • Average True Range (ATR)
  • IVA 0.24
  • CZNC 0.41
  • MACD
  • IVA -0.01
  • CZNC -0.09
  • Stochastic Oscillator
  • IVA 13.95
  • CZNC 10.43

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About CZNC Citizens & Northern Corp

Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.

Share on Social Networks: